An Assessment of the Knowledge and Perceptions of Precision Medicine (PM) in the Rwandan Healthcare Setting

被引:3
作者
Musanabaganwa, Clarisse [1 ,2 ]
Ruton, Hinda [3 ]
Ruhangaza, Deogratias [4 ]
Nsabimana, Nicaise [4 ]
Kayitare, Emmanuel [4 ]
Muvunyi, Thierry Zawadi [5 ]
Semakula, Muhammed [1 ]
Ntirenganya, Faustin [6 ]
Musoni, Emile [6 ]
Ndoli, Jules [7 ]
Hategekimana, Elisee [7 ]
Nassir, Angus [8 ]
Makokha, Francis [9 ]
Uwimana, Aline [10 ]
Gasana, Joel [1 ]
Munezero, Pierre Celestin [11 ]
Uwinkindi, Francois [12 ]
Muvunyi, Claude Mambo [1 ]
Nyirazinyoye, Laetitia [3 ]
Mazarati, Jean Baptiste [13 ]
Mutesa, Leon [2 ]
机构
[1] Rwanda Biomed Ctr, Div Res Innovat & Data Sci, POB 7162, Kigali, Rwanda
[2] Univ Rwanda, Coll Med & Hlth Sci, Ctr Human Genet, POB 4285, Kigali, Rwanda
[3] Univ Rwanda, Sch Publ Hlth, POB 3286, Kigali, Rwanda
[4] Butaro Dist Hosp, POB 59, Burera, Rwanda
[5] King Faisal Hosp, POB 2534, Kigali, Rwanda
[6] Univ Teaching Hosp Kigali, POB 655, Kigali, Rwanda
[7] Univ Teaching Hosp Butare, POB 254, Huye, Rwanda
[8] Kenya Inst Bioinfomat, POB 918, Nairobi, Kenya
[9] Mt Kenya Univ, Directorate Res & Dev, POB 342-01000, Thika, Kenya
[10] Rwanda Biomed Ctr, Malaria & Other Parasit Dis Div, POB 7162, Kigali, Rwanda
[11] Univ Rwanda, Coll Med & Hlth Sci, Sch Med, Dept Microbiol & Parasitol, POB 117, Huye, Rwanda
[12] Rwanda Biomed Ctr, Div Noncommunicable Dis, POB 7162, Kigali, Rwanda
[13] Univ Global Hlth Equ, Sch Med, POB 6955, Kigali, Rwanda
关键词
precision or personalized medicine; breast cancer; healthcare providers; national policies; cancer healthcare services; TRANSLATIONAL GENOMICS; PERSONALIZED MEDICINE; OPPORTUNITIES;
D O I
10.3390/jpm13121707
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Introduction: Precision medicine (PM) or personalized medicine is an innovative approach that aims to tailor disease prevention and treatment to consider the differences in people's genes, environments, and lifestyles. Although many efforts have been made to accelerate the universal adoption of PM, several challenges need to be addressed in order to advance PM in Africa. Therefore, our study aimed to establish baseline data on the knowledge and perceptions of the implementation of PM in the Rwandan healthcare setting. Method: A descriptive qualitative study was conducted in five hospitals offering diagnostics and oncology services to cancer patients in Rwanda. To understand the existing policies regarding PM implementation in the country, two additional institutions were surveyed: the Ministry of Health (MOH), which creates and sets policies for the overall vision of the health sector, and the Rwanda Biomedical Center (RBC), which coordinates the implementation of health sector policies in the country. The researchers conducted 32 key informant interviews and assessed the functionality of available PM equipment in the 5 selected health facilities. The data were thematically categorized and analyzed. Results: The study revealed that PM is perceived as a complex and expensive program by most health managers and health providers. The most cited challenges to implementing PM included the following: the lack of policies and guidelines; the lack of supportive infrastructures and limited suppliers of required equipment and laboratory consumables; financial constraints; cultural, behavioral, and religious beliefs; and limited trained, motivated, and specialized healthcare providers. Regarding access to health services for cancer treatment, patients with health insurance pay 10% of their medical costs, which is still too expensive for Rwandans. Conclusion: The study participants highlighted the importance of PM to enhance healthcare delivery if the identified barriers are addressed. For instance, Rwandan health sector leadership might consider the creation of specialized oncology centers in all or some referral hospitals with all the necessary genomic equipment and trained staff to serve the needs of the country and implement a PM program.
引用
收藏
页数:13
相关论文
共 38 条
[1]   The challenges of the expanded availability of genomic information: an agenda-setting paper [J].
Borry P. ;
Bentzen H.B. ;
Budin-Ljøsne I. ;
Cornel M.C. ;
Howard H.C. ;
Feeney O. ;
Jackson L. ;
Mascalzoni D. ;
Mendes Á. ;
Peterlin B. ;
Riso B. ;
Shabani M. ;
Skirton H. ;
Sterckx S. ;
Vears D. ;
Wjst M. ;
Felzmann H. .
Journal of Community Genetics, 2018, 9 (2) :103-116
[2]  
Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI [10.3322/caac.21492, 10.3322/caac.21609]
[3]   Cancer Precision Medicine: From Cancer Screening to Drug Selection and Personalized Immunotherapy [J].
Deng, Xiaolan ;
Nakamura, Yusuke .
TRENDS IN PHARMACOLOGICAL SCIENCES, 2017, 38 (01) :15-24
[4]   Precision medicine in 2030-seven ways to transform healthcare [J].
Denny, Joshua C. ;
Collins, Francis S. .
CELL, 2021, 184 (06) :1415-1419
[5]   Precision Medicine-A Demand Signal for Genomics Education [J].
Doll, Bruce ;
De Castro, Mauricio J. ;
Fries, Melissa H. ;
Pock, Arnyce R. ;
Seibert, Diane ;
Yang, Wendy .
MILITARY MEDICINE, 2022, 187 :40-46
[6]   Patients' and professionals' views related to ethical issues in precision medicine: a mixed research synthesis [J].
Erdmann, Anke ;
Rehmann-Sutter, Christoph ;
Bozzaro, Claudia .
BMC MEDICAL ETHICS, 2021, 22 (01)
[7]   The opportunity in African genome resource for precision medicine [J].
Fatumo, Segun .
EBIOMEDICINE, 2020, 54
[8]  
Fox Brent I, 2016, Hosp Pharm, V51, P950, DOI 10.1310/hpj5111-950
[9]   A View on Genomic Medicine Activities in Africa: Implications for Policy [J].
Jongeneel, C. Victor ;
Kotze, Maritha J. ;
Bhaw-Luximon, Archana ;
Fadlelmola, Faisal M. ;
Fakim, Yasmina J. ;
Hamdi, Yosr ;
Kassim, Samar Kamal ;
Kumuthini, Judit ;
Nembaware, Victoria ;
Radouani, Fouzia ;
Tiffin, Nicki ;
Mulder, Nicola .
FRONTIERS IN GENETICS, 2022, 13
[10]   Seven Questions for Personalized Medicine [J].
Joyner, Michael J. ;
Paneth, Nigel .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2015, 314 (10) :999-1000